Literature DB >> 2324107

The tryptic activation pathway of monomeric procarboxypeptidase A.

J Vendrell1, C M Cuchillo, F X Avilés.   

Abstract

Procarboxypeptidases are the remaining major digestive zymogens the activation process of which remains unsolved. Here it is shown that in the tryptic activation of monomeric procarboxypeptidase A from porcine pancreas, the generation of carboxypeptidase A (CPA) activity parallels the limited proteolysis of the 94-residue activation segment. This degradation proceeds from the COOH-terminal end of the molecule, and CPA itself makes an important and unexpected contribution by excising the COOH-terminal arginine residue of the released primary activation fragment. Successive cleavages at some of the peptide bonds of the activation segment nearest to the COOH terminus were found to be of prime importance in eliciting CPA activity, particularly those involving the carbonyl groups of Arg94 and Gly93 which were first cleaved. It is also shown that the rate of activation does not depend directly upon the generation of CPA-alpha and its conversion to CPA-beta.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  NMR solution structure of the activation domain of human procarboxypeptidase A2.

Authors:  M Angeles Jiménez; Virtudes Villegas; Jorge Santoro; Luis Serrano; Josep Vendrell; Francesc X Avilés; Manuel Rico
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2.

Authors:  Richárd Szmola; Melinda Bence; Andrea Carpentieri; András Szabó; Catherine E Costello; John Samuelson; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 3.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.

Authors:  I García-Sáez; D Reverter; J Vendrell; F X Avilés; M Coll
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

5.  The activation pathway of procarboxypeptidase B from porcine pancreas: participation of the active enzyme in the proteolytic processing.

Authors:  V Villegas; J Vendrell; X Avilés
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

6.  Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.

Authors:  Sebastián A Testero; Carla Granados; Daniel Fernández; Pablo Gallego; Giovanni Covaleda; David Reverter; Josep Vendrell; Francesc X Avilés; Irantzu Pallarès; Shahriar Mobashery
Journal:  ACS Med Chem Lett       Date:  2017-09-22       Impact factor: 4.345

7.  Crystal structure and mechanism of human carboxypeptidase O: Insights into its specific activity for acidic residues.

Authors:  Maria C Garcia-Guerrero; Javier Garcia-Pardo; Esther Berenguer; Roberto Fernandez-Alvarez; Gifty B Barfi; Peter J Lyons; Francesc X Aviles; Robert Huber; Julia Lorenzo; David Reverter
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-10       Impact factor: 11.205

8.  cDNA cloning and sequence analysis of human pancreatic procarboxypeptidase A1.

Authors:  L Catasús; V Villegas; R Pascual; F X Avilés; C Wicker-Planquart; A Puigserver
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

9.  The NMR structure of the activation domain isolated from porcine procarboxypeptidase B.

Authors:  J Vendrell; M Billeter; G Wider; F X Avilés; K Wüthrich
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

10.  Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity.

Authors:  M Coll; A Guasch; F X Avilés; R Huber
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.